COST-EFFECTIVENESS OF ABATACEPT FOR THE TREATMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS AFTER AN INADEQUATE RESPONSE TO METHOTREXATE IN CHILE

被引：0
|
作者：
Elgart, J. F. [1 ]
Gonzalez, L. [1 ]
Aiello, E. C. [2 ]
机构：
[1] UNLP CONICET La Plata, Ctr Colaborador OPS OMS, CENEXA Ctr Endocrinol Expt & Aplicada, La Plata, Buenos Aires, Argentina
[2] Bristol Myers Squibb, Buenos Aires, DF, Argentina
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 03期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A223 / A223
页数：1
相关论文
共 50 条
  • [31] COST-EFFECTIVENESS OF BIOLOGIC AGENTS COMPARED WITH METHOTREXATE IN THE TREATMENT OF RHEUMATOID ARTHRITIS IN COLOMBIA
    Valle-Mercado, C.
    Cubides, M. F.
    Parra-Torrado, M.
    Rosselli, D.
    VALUE IN HEALTH, 2011, 14 (07) : A311 - A311
  • [32] COST-EFFECTIVENESS ANALYSIS OF SUBCUTANEOUS TOCILIZUMAB WITHOUT METHOTREXATE IN RHEUMATOID ARTHRITIS TREATMENT
    Oksuz, E.
    Malhan, S.
    Yanik, L.
    Koc, E.
    Erdogan-Ciftci, E.
    Celik, H.
    Orfanos, P.
    VALUE IN HEALTH, 2018, 21 : S297 - S297
  • [33] Cost-effectiveness of biological therapy compared with methotrexate in the treatment for rheumatoid arthritis in Colombia
    Carolina Valle-Mercado
    Maria-Fernanda Cubides
    Monica Parra-Torrado
    Diego Rosselli
    Rheumatology International, 2013, 33 : 2993 - 2997
  • [34] Cost-effectiveness of biological therapy compared with methotrexate in the treatment for rheumatoid arthritis in Colombia
    Valle-Mercado, Carolina
    Cubides, Maria-Fernanda
    Parra-Torrado, Monica
    Rosselli, Diego
    RHEUMATOLOGY INTERNATIONAL, 2013, 33 (12) : 2993 - 2997
  • [35] Long-term efficacy and safety of abatacept through 5 years of treatment in rheumatoid arthritis patients with an inadequate response to methotrexate
    Emery, P.
    Kremer, J.
    Moreland, L.
    Russell, A.
    Li, T.
    Aranda, R.
    Becker, J. C.
    Tsai, K.
    Dougados, M.
    Westhovens, R.
    RHEUMATOLOGY, 2008, 47 : II48 - II48
  • [36] Cost-effectiveness of anakinra plus methotrexate versus methotrexate alone for the treatment of rheumatoid arthritis.
    Guh, DP
    Marra, CA
    Woolcott, JC
    Gignac, M
    Esdaile, JM
    Clarke, A
    Anis, AH
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S264 - S264
  • [37] Phase II dose-response study of abatacept in Japanese patients with active rheumatoid arthritis with an inadequate response to methotrexate
    Takeuchi, Tsutomu
    Matsubara, Tsukasa
    Nitobe, Taisuke
    Suematsu, Eiichi
    Ohta, Syuji
    Honjo, Shigeru
    Abe, Tohru
    Yamamoto, Ami
    Miyasaka, Nobuyuki
    MODERN RHEUMATOLOGY, 2013, 23 (02) : 226 - 235
  • [38] Cost-Effectiveness of Baricitinib for Patients with Moderate-to-Severe Rheumatoid Arthritis After Methotrexate Failed in China
    SiNi Li
    JianHe Li
    LiuBao Peng
    YaMin Li
    XiaoMin Wan
    Rheumatology and Therapy, 2021, 8 : 863 - 876
  • [39] Cost-Effectiveness of Baricitinib for Patients with Moderate-to-Severe Rheumatoid Arthritis After Methotrexate Failed in China
    Li, SiNi
    Li, JianHe
    Peng, LiuBao
    Li, YaMin
    Wan, XiaoMin
    RHEUMATOLOGY AND THERAPY, 2021, 8 (02) : 863 - 876
  • [40] INVESTIGATING THE VALUE OF ABATACEPT IV IN THE TREATMENT OF RHEUMATOID ARTHRITIS: A SYSTEMATIC REVIEW OF COST-EFFECTIVENESS STUDIES
    Athanasakis, K.
    Petrakis, I
    Kyriopoulos, J.
    VALUE IN HEALTH, 2013, 16 (07) : A563 - A563
12345